Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia.

Hijiya N, Gaynon P, Barry E, Silverman L, Thomson B, Chu R, Cooper T, Kadota R, Rytting M, Steinherz P, Shen V, Jeha S, Abichandani R, Carroll WL.

Leukemia. 2009 Dec;23(12):2259-64. doi: 10.1038/leu.2009.185. Epub 2009 Sep 10.

PMID:
19741725
2.

Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup.

Huguet F, Leguay T, Raffoux E, Rousselot P, Vey N, Pigneux A, Ifrah N, Dombret H.

Leuk Lymphoma. 2015 Apr;56(4):847-57. doi: 10.3109/10428194.2014.887708. Review.

PMID:
24996442
3.

The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.

McGregor BA, Brown AW, Osswald MB, Savona MR.

Am J Hematol. 2009 Apr;84(4):228-30. doi: 10.1002/ajh.21365. Review.

4.

Clofarabine in pediatric acute leukemia: current findings and issues.

Hijiya N, Barry E, Arceci RJ.

Pediatr Blood Cancer. 2012 Sep;59(3):417-22. doi: 10.1002/pbc.24112. Epub 2012 Feb 21. Review.

PMID:
22354543
5.

The role of Clofarabine in the treatment of adults with acute myeloid leukemia.

Fozza C.

Crit Rev Oncol Hematol. 2015 Mar;93(3):237-45. doi: 10.1016/j.critrevonc.2014.10.009. Epub 2014 Oct 22. Review.

PMID:
25457773
6.

Etoposide in acute leukemia. Past experience and future perspectives.

Ho AD, Brado B, Haas R, Hunstein W.

Cancer. 1991 Jan 1;67(1 Suppl):281-4. Review.

7.

Clofarabine.

[No authors listed]

Drugs R D. 2004;5(4):213-7. Review.

PMID:
15230627
8.

High-dose etoposide in allogeneic stem cell transplantation.

Bruserud O, Reikvam H, Kittang AO, Ahmed AB, Tvedt TH, Sjo M, Hatfield KJ.

Cancer Chemother Pharmacol. 2012 Dec;70(6):765-82. doi: 10.1007/s00280-012-1990-z. Epub 2012 Oct 6. Review.

PMID:
23053272
9.

Hypertension and Life-Threatening Bleeding in Children with Relapsed Acute Myeloblastic Leukemia Treated with FLT3 Inhibitors.

Yılmaz Karapınar D, Karadaş N, Önder Siviş Z, Balkan C, Kavaklı K, Aydınok Y.

Turk J Haematol. 2015 Sep;32(3):263-6. doi: 10.4274/tjh.2014.0250. Epub 2015 Apr 27. Review.

10.

Nelarabine in the treatment of pediatric and adult patients with T-cell acute lymphoblastic leukemia and lymphoma.

Kadia TM, Gandhi V.

Expert Rev Hematol. 2017 Jan;10(1):1-8. doi: 10.1080/17474086.2017.1262757. Epub 2016 Dec 8. Review.

PMID:
27869523
11.

Treating adults with acute lymphocytic leukemia: new pharmacotherapy options.

Thomas X, Le Jeune C.

Expert Opin Pharmacother. 2016 Dec;17(17):2319-2330. Epub 2016 Oct 31. Review.

PMID:
27759440
12.

The adolescent and young adult with cancer: state of the art-- acute leukemias.

Gramatges MM, Rabin KR.

Curr Oncol Rep. 2013 Aug;15(4):317-24. doi: 10.1007/s11912-013-0325-5. Review.

13.

Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute Leukemia.

Shalabi H, Angiolillo A, Fry TJ.

Front Pediatr. 2015 Oct 1;3:80. doi: 10.3389/fped.2015.00080. eCollection 2015. Review.

14.

A systematic review of treatment outcomes with weight-based dosing of chemotherapy in obese adult patients with acute leukemia or lymphoma.

Mapp S, Sandhu G, Carrington C, Hennig S.

Leuk Lymphoma. 2016;57(4):981-4. doi: 10.3109/10428194.2015.1087520. Epub 2015 Oct 12. Review. No abstract available.

PMID:
26325127
15.

Advancements in the treatment of pediatric acute leukemia and brain tumor - continuous efforts for 100% cure.

Ju HY, Hong CR, Shin HY.

Korean J Pediatr. 2014 Oct;57(10):434-9. doi: 10.3345/kjp.2014.57.10.434. Epub 2014 Oct 31. Review.

Supplemental Content

Support Center